» Articles » PMID: 38455817

A Comprehensive Review of the Immunomodulatory Effects of Vitamin D in Sepsis

Overview
Journal Cureus
Date 2024 Mar 8
PMID 38455817
Authors
Affiliations
Soon will be listed here.
Abstract

Sepsis remains a critical global health challenge characterised by a dysregulated immune response to infection, leading to systemic inflammation and organ dysfunction. This review examines the immunomodulatory effects of Vitamin D in sepsis, focusing on its regulation of immune cell function, modulation of cytokine production, and enhancement of antimicrobial responses. While the potential of Vitamin D as an adjunctive therapy in sepsis management is evident, challenges such as variability in Vitamin D status, uncertainties regarding optimal dosages and patient heterogeneity, and potential adverse effects require careful consideration. The review highlights the implications for future research and clinical practice, emphasising the need for standardised measurement protocols, elucidation of optimal supplementation strategies, and integration of Vitamin D assessments into routine care. Despite the complexities, Vitamin D emerges as a promising avenue for personalised interventions in sepsis, necessitating ongoing research collaboration and evidence-based guidelines to harness its full therapeutic potential and improve clinical outcomes.

Citing Articles

Vitamin D supplementation may be beneficial in improving the prognosis of patients with sepsis-associated acute kidney injury in the intensive care unit: a retrospective study.

Sun J, Wang Y, Wang J, Wu H, Xu Z, Niu D Front Med (Lausanne). 2024; 11:1453522.

PMID: 39687902 PMC: 11646774. DOI: 10.3389/fmed.2024.1453522.


Nutritional and metabolic modulation of inflammation in critically ill patients: a narrative review of rationale, evidence and grey areas.

Rousseau A, Martindale R Ann Intensive Care. 2024; 14(1):121.

PMID: 39088114 PMC: 11294317. DOI: 10.1186/s13613-024-01350-x.


25-hydroxyvitamin D and parathyroid hormone in new onset sepsis: A prospective study in critically ill patients.

Karampela I, Stratigou T, Antonakos G, Kounatidis D, Vallianou N, Tsilingiris D Metabol Open. 2024; 23:100296.

PMID: 38983450 PMC: 11228765. DOI: 10.1016/j.metop.2024.100296.

References
1.
Nair P, Venkatesh B, Center J . Vitamin D deficiency and supplementation in critical illness-the known knowns and known unknowns. Crit Care. 2018; 22(1):276. PMC: 6205786. DOI: 10.1186/s13054-018-2185-8. View

2.
Iyer S, Cheng G . Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012; 32(1):23-63. PMC: 3410706. DOI: 10.1615/critrevimmunol.v32.i1.30. View

3.
Roffe-Vazquez D, Huerta-Delgado A, Castillo E, Villarreal-Calderon J, Gonzalez-Gil A, Enriquez C . Correlation of Vitamin D with Inflammatory Cytokines, Atherosclerotic Parameters, and Lifestyle Factors in the Setting of Heart Failure: A 12-Month Follow-Up Study. Int J Mol Sci. 2019; 20(22). PMC: 6887713. DOI: 10.3390/ijms20225811. View

4.
Deeb K, Trump D, Johnson C . Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007; 7(9):684-700. DOI: 10.1038/nrc2196. View

5.
Shojaei M, Sabzeghabaei A, Valaei Barhagh H, Soltani S . The Correlation between Serum Level of Vitamin D and Outcome of Sepsis Patients; a Cross-Sectional Study. Arch Acad Emerg Med. 2019; 7(1):e1. PMC: 6377223. View